Volkswagen recalls over 170,000 vehicles. See impacted models
The Reston, Virginia-headquartered carmaker, which is a subsidiary of the Volkswagen Group of automobile companies of Germany, said the recall issued on May 22 impacts certain 2024-2025 Atlas Cross Sport and Atlas vehicles.
The software error could cause the review camera image to become distorted when the car is in reverse, the NHTSA says. Due to this, the vehicles fail to comply with the Federal Motor Vehicle Safety requirements, the government agency said.
"A distorted rearview camera image can reduce the driver's view of what is behind the vehicle, increasing the risk of a crash," according to the NHTSA.
The Volkswagen models impacted by the recall include:
Volkswagen Atlas 2024-25
Volkswagen Atlas Cross Sport 2024-25
The NHTSA said dealers will update the camera control unit software, free of charge.
Owner notification letters should be mailed by July 18, according to the government agency. Owners can also contact Volkswagen customer service at 1-800-893-5298.
Volkswagen's number for this recall is 91SB.
Jonathan Limehouse covers breaking and trending news for USA TODAY. Reach him at JLimehouse@gannett.com.
This article originally appeared on USA TODAY: Volkswagen recalls more than 170k Atlas vehicles over software error
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
Canadian toll firm hires US construction exec as CEO
This story was originally published on Construction Dive. To receive daily news and insights, subscribe to our free daily Construction Dive newsletter. Jose Espinosa is taking the reins as president and CEO of toll highway company 407 ETR, according to a news release from the Woodbridge, Ontario-based firm. He brings to the role more than 25 years of international experience in tolling and highway infrastructure across the U.S., Canada, Europe and Australia. Espinosa succeeded Javier Tamargo, who served as president and CEO since September 2020, on July 16. Tamargo is now CEO of Austin, Texas-headquartered highway firm Cintra US, a subsidiary of Amsterdam-headquartered civil engineering company Ferrovial. Espinosa also joined the 407 ETR board of directors this month. His appointment is a return to the firm: Between 2009 and 2016, Espinosa worked as corporate shareholder liaison and reporting manager, and later as project director for Highway 407 ETR East operations, per the release. Espinosa recently served as CEO of three North Texas highways — the Lyndon B. Johnson Expressway, North Tarrant Express and North Tarrant Express 35W — where he worked to increase capacity and connectivity on main arteries in the Dallas-Fort Worth area, per the release. Prior to that, he served as CEO at I-77 Mobility Partners in Charlotte, North Carolina. Previously, Espinosa also worked at Ferrovial, starting in 2000 as an analyst in the corporate treasury department and progressing through several management positions at Madrid-based Cintra, according to his company biography page. "Mr. Espinosa comes with a proven track record in complex infrastructure management and is well positioned to lead 407 ETR through its next phase of growth and operational excellence. His global experience will be instrumental as we continue to drive innovation, enhance the customer experience, and deliver long-term value to our stakeholders," said 407 International Board Chair David McFadden in the release. Recommended Reading Sundt promotes from within for Southwest division leader Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Krispy Kreme Is Getting Some Meme Investor Love. How Should You Play DNUT Stock Here?
Krispy Kreme (DNUT) shares opened roughly 40% higher today as meme stock enthusiasts shifted focus from the likes of Opendoor (OPEN) and Kohl's (KSS) to the doughnut company. According to multiple sources, more than 30% of DNUT's float is currently sold short, making it a prime candidate for a short squeeze. More News from Barchart Nvidia Stock Warning: This NVDA Challenger Just Scored a Major Customer Dear Microsoft Stock Fans, Mark Your Calendars for July 30 Dear QuantumScape Stock Fans, Mark Your Calendars for July 23 Markets move fast. Keep up by reading our FREE midday Barchart Brief newsletter for exclusive charts, analysis, and headlines. While Krispy Kreme stock has pared back some of its intraday gains in recent hours, at one point, it was seen trading well over 100% up versus its year-to-date low set in late June. Why Is It Risky to Chase the Meme Stock Rally in Krispy Kreme Stock? The meme stock frenzy in DNUT shares offered lucrative returns to investors this morning, but chasing that momentum now may prove a textbook case of trying to catch a falling knife, according to Daniela Sabin Hathorn – a analyst. 'The risks are just as stark as the rewards,' she write in a research note today, adding retail driven rallies like the one in Krispy Kreme stock on Wednesday are often 'disconnected from fundamentals' and, therefore, run the risk of reversing just as quickly. In short, Hathorn recommends accepting the ship has already sailed instead of initiating a position in the food company on the pullback – hoping another short squeeze may materialize in it in the coming days. Sinking Revenue Remains an Overhang for DNUT Shares Investors should practice caution in owning Krispy Kreme shares amid ongoing speculation also because the company's financials remain deeply challenged. In its latest reported quarter, the Charlotte-headquartered firm generated roughly $375 million in revenue, down a more-than-expected 15% on a year-over-year basis. Additionally, Krispy Kreme continued to burn cash, losing about $0.05 on a per-share basis in its fiscal Q1. Krispy Kreme Is Trading Well Below the Street's Mean Target Despite thin financials and risks related to the company's newly earned meme stock status, Wall Street analysts believe DNUT shares have significant room to the upside from current levels. While the consensus rating on Krispy Kreme stock sits at 'Hold' only, the mean target of roughly $6.33 indicates potential upside of more than 45% from here. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Yahoo
an hour ago
- Yahoo
Trump Threatens To Ban European Car Sales If Drug Companies Don't Lower Prices Because That Makes Sense
Donald Trump has a lot of thoughts. Most of them don't make any sense, and the sentences themselves are often barely intelligible, but that doesn't mean he doesn't still have thoughts. If he were in memory care, like he probably should be, that would be one thing, but instead, he's our president, so his incoherent ramblings are once again the entire world's problem. For example, just this week, Trump said he'll ban European automakers from selling cars here if pharmaceutical companies don't lower their prices. You know, because that makes sense. While speaking on lowering drug prices in the U.S., Trump said we need to get "the other countries to lift up their prices a little bit and to get the drug companies to put it to them. And if they don't, the drug companies will have [sic] lot of problems, and they are mostly agreed to it. And if the countries don't, then, as an example, if it's Europe, I'll say, 'That's OK. You're no longer allowed to sell cars in America. You're no longer allowed to have Mercedes, BMW, Volkswagen or any of the other many cars,' and they will say, 'Oh, I love the idea of lower drug prices for America. So you have to use that." Now, it's worth noting that Europe is a continent, not a country, and the European Union is, well, a political union made up of many individual countries, but that also isn't the main point here. More importantly, he's saying he wants pharmaceutical companies to lower their prices in the U.S., and if they don't, he'll ban separate, unrelated companies — in this case, automakers — from doing business in the U.S. Apparently, it's BMW's responsibility to force Pfizer to lower its prices. Or something. Maybe the EU is supposed to force drug companies to lower their prices so the automakers don't get punished? Read more: Save Your Engine: 5 Tips For Preventing And Cleaning Carbon Buildup None Of This Makes Any Sense To borrow a phrase from Michael Tae Sweeney, 10,000 Tariff Grandpa has his good days and his bad days, but mostly, it's just bad days now. And sure, he's under a lot of pressure lately with considering all the stories coming out about how close his relationship was with infamous sex trafficker Jeffrey Epstein. But on a fundamental level, his threat just doesn't make any sense. Why would you punish Volkswagen because Eli Lilly did something you don't like? If I told you I was suing Costco because I was mad Ford refused to give us a new Fiesta ST, you'd look at me like I had lost my mind. You would also be correct to do so. And yet, here's the President of the United States saying something equally nonsensical. Sure, there will probably be plenty of bootlickers who come out of the woodwork to say he didn't really mean it, he'd never actually do it and I have Trump Derangement Syndrome if I think the words spoken out loud by the actual president matter, but come on. I mean, come on. How would this even work? Would he only ban imports, or would he ban all vehicle sales? European automakers already build a crap-ton of vehicles here, so that's a pretty big question. Would he shut down BMW's factory in Greer, South Carolina? And what would he do about Stellantis? That's a European company. Is Trump going to ban Jeep because it's no longer owned by a company headquartered in the U.S.? Perhaps most importantly, how would punishing automakers force Merck to lower its prices? Additionally, aren't Republicans supposed to be the party of small government? Would this not be an egregious example of federal overreach? Do Republicans no longer care about the president being mentally fit for office now that their guy is in charge? I think we all know the answers to those questions, but it doesn't make Trump's threats to ban European car sales if drug companies don't lower their prices any less nonsensical or unhinged. Want more like this? Join the Jalopnik newsletter to get the latest auto news sent straight to your inbox... Read the original article on Jalopnik.
